TY - JOUR
T1 - Dietary intake and physical activity in Japanese patients with type 2 diabetes
T2 - the Japan Diabetes Complication and its Prevention prospective study (JDCP study 8)
AU - JDCP Study Group
AU - Horikawa, Chika
AU - Tsuda, Kinsuke
AU - Oshida, Yoshiharu
AU - Satoh, Jo
AU - Hayashino, Yasuaki
AU - Tajima, Naoko
AU - Nishimura, Rimei
AU - Sone, Hirohito
AU - Koya, Daisuke
AU - Shikata, Kenichi
AU - Kitano, Shigehiko
AU - Sato, Yukihiro
AU - Yamashita, Hidetoshi
AU - Kato, Satoshi
AU - Nakamura, Jiro
AU - Baba, Masayuki
AU - Shimano, Hitoshi
AU - Yamasaki, Yoshimitsu
AU - Yoshioka, Naruhito
AU - Sasaki, Satoshi
AU - Sato, Jo
AU - Sone, Hirohito
AU - Izumi, Kazuo
AU - Origasa, Hideki
AU - Inagaki, Kouji
AU - Nishimura, Fusanori
AU - Noguchi, Hidetoshi
AU - Yoshioka, Naruhito
AU - Sato, Jo
AU - Nakamura, Jiro
AU - Inagaki, Nobuya
AU - Tanizawa, Yukio
AU - Araki, Eiichi
AU - Araki, Eiichi
AU - Izumi, Kazuo
AU - Inagaki, Nobuya
AU - Ueki, Kohjiro
AU - Sone, Hirohito
AU - Nishimura, Yukio Tanizawa Rimei
AU - Noda, Mitsuhiko
AU - Iwamoto, Yasuhiko
AU - Kasuga, Masato
AU - Nanjo, Kishio
AU - Haneda, Masakazu
AU - Hotta, Nigishi
AU - Kasuga, Masato
AU - Iso, Yasuhiro
AU - Kiyohara, Hiroshi
AU - Haneda, Masakazu
AU - Yamauchi, Toshimasa
N1 - Funding Information:
We thank all the patients, staff and the diabetologists all over Japan for their long-standing collaboration in this study. We thank Satoshi Sasaki, M.D., Ph.D., Professor in the Department of Social and Preventive Epidemiology, School of Public Health, the University of Tokyo, for helpful nutritional advice. Thanks are also extended to Ms. Mami Haga, Niigata University, for their excellent secretarial assistance. JDCP Study Investigators JDCP Study Working Groups (representatives shown with an asterisk [*]). Nephropathy: Kazunori Utsunomiya, Daisuke Koya, Kenichi Shikata*. Retinopathy: Shigehiko Kitano*, Yukihiro Sato, Hidetoshi Yamashita, Satoshi Kato (2021–). Neuropathy: Jiro Nakamura*, Masayuki Baba. Macrovascular disease: Hitoshi Shimano, Yoshimitsu Yamasaki*, Naruhito Yoshioka. Diet therapy: Satoshi Sasaki, Jo Sato, Kinsuke Tsuda*. Exercise therapy: Yoshiharu Oshida, Hirohito Sone*. Epidemiology/statistics: Kazuo Izumi, Hideki Origasa, Rimei Nishimura*, Yasuaki Hayashino. Periodontal disease: Kouji Inagaki*, Fusanori Nishimura, Hidetoshi Noguchi. JDCP Study Regional Leaders: Hokkaido Chapter: Naruhito Yoshioka. Tohoku Chapter: Jo Sato. Kanto-Koshinetsu Chapter: Rimei Nishimura (Principal Investigator). Chubu Chapter: Jiro Nakamura. Kinki Chapter: Nobuya Inagaki. Chugoku-Shikoku Chapter: Yukio Tanizawa. Kyushu Chapter: Eiichi Araki. JDCP Study Coordination Committee: Objective: To make key decisions relating to the research project to ensure appropriate and smooth conduct of the study. Members of the Committee: Eiichi Araki, Kazuo Izumi, Nobuya Inagaki, Kohjiro Ueki, Hirohito Sone, Naoko Tajima, Yukio Tanizawa Rimei Nishimura*, Mitsuhiko Noda, Yasuaki Hayashino. JDCP Study Steering Committee (SSC): Objective: To provide guidance on key issues in the conduct of the study, with the committee set up within the JDS; to receive reports from the SCC; to make recommendations to the SCC as required; and to assess the progress of the study as well as its outcomes and report to the JDS as to whether the study is being conducted appropriately. Members of the Committee: (First-termers, 2009–2012): Yasuhiko Iwamoto, Masato Kasuga, Kishio Nanjo (Chair), Masakazu Haneda, Nigishi Hotta. (Second-termers, 2013–2017): Masato Kasuga (Chair), Yasuhiro Iso, Hiroshi Kiyohara, Masakazu Haneda, Toshimasa Yamauchi, Tsutomu Yamazaki. (Third-termers, 2018–2022): Eiichi Araki (Chair), Jiro Nakamura, Yasuhiro Iso, Hiroshi Kiyohara, Toshimasa Yamauchi, Tsutomu Yamazaki.
Funding Information:
Jo Satoh received honoraria from Boehringer Ingelheim, Eli Lilly and Company, MSD, Ono Pharmaceutical Co., Ltd., Sanofi, and Sumitomo Dainippon Pharma Co., Ltd. Yasuaki Hayashino received a research grant from Ono Pharmaceutical Co., Ltd. Rimei Nishimura received honoraria from Sanofi, Medtronic Japan Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Takeda Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Novo Nordisk Pharma Ltd., MSD, and Astellas Pharma lnc., and received subsidies or donations from Taisho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Ltd., and Nippon Boehringer Ingelheim Co., Ltd. Hirohito Sone received a research grant from Novo Nordisk Pharma Ltd., and reports endowed departments by commercial entities from Novo Nordisk Pharma Ltd., Eisai Co., Ltd., Kyowa Kirin Co., Ltd. Astellas Pharma Inc., Taisho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. Chika Horikawa, Kinsuke Tsuda, Yoshiharu Oshida, and Naoko Tajima declare that they have no conflict of interest.
Publisher Copyright:
© 2022, The Japan Diabetes Society.
PY - 2022/4
Y1 - 2022/4
N2 - Medical nutrition therapy and exercise therapy are the cornerstones of treatment for patients with type 2 diabetes; however, there has not been a nationwide study on the actual dietary intake and physical activity status of patients since the 2000s. We aimed to clarify this in Japanese patients with type 2 diabetes using data from the Japan Diabetes Complication and its Prevention prospective (JDCP), a nationwide study launched in 2007. A total of 1992 patients with type 2 diabetes, aged 40–75 years, completed either the Brief-type, self-administered Diet History Questionnaire (1643 patients) or International Physical Activity Questionnaire (1834 patients), and their data were analyzed in this study. Mean daily energy intake for all participants was 1686.8 kcal/day, and the mean proportions of carbohydrate, protein, and fat comprising total energy intake were 60.2, 16.2, and 23.6%, respectively. The patients in this study had similar energy and nutrient intake status to patients in the 1996 Japan Diabetes Complications Study; however, Japanese patients still had higher carbohydrate and lower fat consumption than patients with diabetes in Western countries. The physical activity questionnaire reported that 31.0% of patients did not have exercise habits; this was particularly noticeable in female patients and patients under the age of 65. BMI increased from 22.7 to 24.1 kg/m2 in men and 23.2 to 24.8 kg/m2 in women from 1996 to 2007, respectively. Further research is required to investigate how dietary intake and physical activity associates with the risk of developing complications in type 2 diabetes patients.
AB - Medical nutrition therapy and exercise therapy are the cornerstones of treatment for patients with type 2 diabetes; however, there has not been a nationwide study on the actual dietary intake and physical activity status of patients since the 2000s. We aimed to clarify this in Japanese patients with type 2 diabetes using data from the Japan Diabetes Complication and its Prevention prospective (JDCP), a nationwide study launched in 2007. A total of 1992 patients with type 2 diabetes, aged 40–75 years, completed either the Brief-type, self-administered Diet History Questionnaire (1643 patients) or International Physical Activity Questionnaire (1834 patients), and their data were analyzed in this study. Mean daily energy intake for all participants was 1686.8 kcal/day, and the mean proportions of carbohydrate, protein, and fat comprising total energy intake were 60.2, 16.2, and 23.6%, respectively. The patients in this study had similar energy and nutrient intake status to patients in the 1996 Japan Diabetes Complications Study; however, Japanese patients still had higher carbohydrate and lower fat consumption than patients with diabetes in Western countries. The physical activity questionnaire reported that 31.0% of patients did not have exercise habits; this was particularly noticeable in female patients and patients under the age of 65. BMI increased from 22.7 to 24.1 kg/m2 in men and 23.2 to 24.8 kg/m2 in women from 1996 to 2007, respectively. Further research is required to investigate how dietary intake and physical activity associates with the risk of developing complications in type 2 diabetes patients.
KW - Dietary intake
KW - Japan
KW - Physical activity
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85132614435&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132614435&partnerID=8YFLogxK
U2 - 10.1007/s13340-022-00575-0
DO - 10.1007/s13340-022-00575-0
M3 - Article
AN - SCOPUS:85132614435
SN - 2190-1678
VL - 13
SP - 344
EP - 357
JO - Diabetology International
JF - Diabetology International
IS - 2
ER -